The Immunohistochemistry Antibody Company

Home
Products
- All Antibodies
- IHC-plus Antibodies
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
Distributors
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us

View Cart

Lung Cancer Screen 88 Tissue Microarray - LS-SLUCA88

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Technical Help email

Request an IHC Study by email

PDF Spec Sheet - click here

Catalog ID:	LS-SLUCA88
Product Name:	Lung Cancer Screen 88
Description:	Lung cancer with stage/grade
Format:	FFPE
Category:	Human Tumor
QA/QC:	H&E reviewed
Storage:	Short term RT; Long term 4ºC
Clinical History:	No
Tissue Marker:	No
Stage/Grade:	Yes
Cases:	48
Cores:	48
Slides Per Set:	1

LS-SLUCA88 Tissue Microarray Map

Slide Number 1

LABEL

	1	2	3	4	5	6	7	8
A	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
B	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
C	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
D	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
E	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
F	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng

Diagnosis Type Legend

Benign non-neoplastic

Diseased

Inflammatory

Malignant

Metastatic

Tumor

Unknown

Element Tissue Legend

Lung (Lng);

LS-SLUCA88 Element Details

Slide	Position	Species	Gender	Age	Tissue	Diagnosis	Diagnosis Type	TNM Tumor Classification	Tumor Grade	Tumor Stage	Tumor Differentiation
1	A1	Human	M	69 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	II
1	A2	Human	M	55 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	A3	Human	M	57 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	1	II
1	A4	Human	M	73 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	A5	Human	M	58 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	A6	Human	M	62 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	II
1	A7	Human	M	55 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	A8	Human	M	70 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	B1	Human	M	51 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	II
1	B2	Human	M	54 y	Lung (Lng)	Squamous cell carcinoma with chronic inflammation	Malignant	T2N0M0		I
1	B3	Human	M	63 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	B4	Human	F	50 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	B5	Human	M	65 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	B6	Human	M	42 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	B7	Human	M	72 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	B8	Human	M	52 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	C1	Human	M	69 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2-3	I
1	C2	Human	M	72 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	II
1	C3	Human	F	46 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T1N0M0	2	I
1	C4	Human	M	30 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	C5	Human	M	46 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N2M0	2	IIIA
1	C6	Human	M	55 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	II
1	C7	Human	M	62 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	C8	Human	M	66 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2-3	I
1	D1	Human	M	57 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	3	I
1	D2	Human	M	59 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	3	I
1	D3	Human	F	46 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	3	I
1	D4	Human	M	60 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	3	I
1	D5	Human	M	57 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	3	I
1	D6	Human	M	48 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	3	I
1	D7	Human	M	52 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	3	I
1	D8	Human	F	57 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	3	I
1	E1	Human	M	67 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	3	I
1	E2	Human	M	62 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	3	II
1	E3	Human	M	58 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	3	II
1	E4	Human	M	66 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	3	I
1	E5	Human	M	54 y	Lung (Lng)	Adenosquamous carcinoma	Malignant	T2N1M0		II
1	E6	Human	M	53 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N0M0	2	I
1	E7	Human	F	56 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N0M0	2	I
1	E8	Human	M	36 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N0M0	2-3	I
1	F1	Human	M	49 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N0M0	3	I
1	F2	Human	F	46 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N0M0	3	I
1	F3	Human	F	51 y	Lung (Lng)	Carcinoma	Malignant	T2N0M0		I	Undifferentiated
1	F4	Human	M	39 y	Lung (Lng)	Small cell carcinoma	Malignant	T2N1M0		II	Undifferentiated
1	F5	Human	M	28 y	Lung (Lng)	Small cell carcinoma	Malignant	T2N1M0		II	Undifferentiated
1	F6	Human	M	58 y	Lung (Lng)	Small cell carcinoma	Malignant	T2N1M0		II	Undifferentiated
1	F7	Human	F	59 y	Lung (Lng)	Small cell carcinoma	Malignant	T2N1M0		II	Undifferentiated
1	F8	Human	M	46 y	Lung (Lng)	Large cell carcinoma	Malignant	T2N0M0		I

PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.